ECG Diagnosis: Wolff-Parkinson-White Syndrome

PDF Download

 

Joel T Levis, MD, FACEP, FAAEM

Summer 2010 - Volume 14 Number 2

https://doi.org/10.7812/TPP/09-141

Wolff-Parkinson-White Syndrome (WPWS) is defined as the presence of an accessory pathway (AP) and has a predisposition to the development of supraventricular tachydysrhythmias. Conduction over an AP circumvents conduction delay occurring within the atrioventricular node (AVN), which leads to early eccentric activation of the ventricles and fusion complexes.1 If WPWS with atrial fibrillation (AF) is treated by drugs that prolong the AVN refractory period (eg, calcium-channel blockers, beta-blockers, digoxin, adenosine), the rate of conduction through the AP may increase and degenerate to ventricular fibrillation (VF).2 Unstable patients with WPWS and AF should receive immediate electrical cardioversion.3 Stable patients can be chemically cardioverted with IV procainamide. Amiodarone should be used with caution due to its ability to cause ventricular rate acceleration and degeneration into VF.3 Ibutilide is considered an alternative agent, although it has numerous side effects.1 Cardiology or electrophysiology consultation with consideration for radiofrequency mapping and ablation should occur for patients presenting with AF in the setting of WPWS.

References
    1.    Levis JT, Garmel GM. Atrial fibrillation with Wolff-Parkinson-White syndrome. Internet J Emerg Med [serial on the Internet] 2009 [cited 2010 Mar 8];5(1) [about 1 p]. Available from: www.ispub.com/ostia/index.php?xmlPrinter=true&xmlFilePath=journals/ijem/vol5n1/wpw.xml.
    2.    Garmel GM. Wide complex tachycardias: understanding this complex condition: Part 1—epidemiology and electrophysiology. West J Emerg Med 2008 Jan;9(1):28-39.
    3.    Fengler BT, Brady WJ, Plautz CU. Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED. Am J Emerg Med 2007 Jun;25(5):576-83.
 

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all published materials is copyrighted and protected.

SUBSCRIPTION

Journal subscriptions for The Permanente Journal are entered for the calendar year. Advance payment in US dollars is required.

CIRCULATION

27,000 print readers per quarter, 15,350 eTOC readers, and in 2018, 2 million page views of TPJ articles in PubMed from a broad international readership.

Indexing

Indexed in MEDLINE, PubMed Central, HINARI, EMBASE, EBSCO Academic Search Complete, rdrb, CrossRef, and SciVerse/Scopus.


                                             

 

 

ISSN 1552-5767 Copyright © 2019 thepermanentejournal.org.

All Rights Reserved.